Effect of Tocilizumab on “Ventilator Free Days” Composite Outcome in SARS-CoV-2 Patients: A Retrospective Competing Risk Analysis

BACKGROUND: SARS-CoV-2 infection demonstrates a wide range of severity. More severe cases demonstrate a cytokine storm with elevated serum interleukin-6, hence IL-6 receptor antibody tocilizumab was tried for the management of severe cases. AIMS: Effect of tocilizumab on ventilator-free days among c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mady, Ahmed F., Abdulrahman, Basheer, Mumtaz, Shahzad A., Al-Odat, Mohammed A., Kuhail, Ahmed, Altoraifi, Rehab, Alshae, Rayan, Alharthy, Abdulrahman M., Karakitsos, Dimitrios, Aletreby, Waleed Th.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949015/
https://www.ncbi.nlm.nih.gov/pubmed/36844963
http://dx.doi.org/10.2478/rjaic-2022-0001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949015/
https://www.ncbi.nlm.nih.gov/pubmed/36844963
http://dx.doi.org/10.2478/rjaic-2022-0001

Ejemplares similares